Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
BMC Urology|September 30, 2023
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancerGiorgio Gandaglia, Riccardo Leni, Sophie Plagakis, et al.
European Urology Focus|January 11, 2021
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and BeyondGiorgio Gandaglia, Riccardo Leni, Nicola Fossati, et al.
European Urology Focus|November 28, 2025
Control of Confounding and Claims of Causality in Observational Studies of Neuraxial Anesthesia and Recurrence in Urologic Cancer: A Systematic ReviewLucia Salerno, Riccardo Leni, Amy L Tin, et al.
European Radiology|July 4, 2024
Is MRI ready to replace biopsy during active surveillance?Adriano B Dias, Sungmin Woo, Riccardo Leni, et al.
The Journal of Urology|July 31, 2024
Management and Oncologic Outcomes of Incidental Prostate Cancer After Transurethral Resection of the Prostate in DenmarkRiccardo Leni, Andrew Julian Vickers, Klaus Brasso, et al.
European Urology Oncology|October 30, 2021
Epidemiology and Prevention of Prostate CancerGiorgio Gandaglia, Riccardo Leni, Freddie Bray, et al.
The World Journal of Men'S Health|January 17, 2023
The Complex Interplay between Serum Testosterone and the Clinical Course of Coronavirus Disease 19 Pandemic: A Systematic Review of Clinical and Preclinical EvidenceRiccardo Leni, Federico Belladelli, Sara Baldini, et al.
Andrology|June 30, 2022
Peyronie's disease development and management in diabetic menSimone Gianazza, Federico Belladelli, Riccardo Leni, et al.
BJU International|May 29, 2025
Magnetic resonance imaging for long-term active surveillance biopsy decision-makingRiccardo Leni, Amy L Tin, Nicole Liso, et al.
BJU International|December 14, 2023
Medium-term follow up of active surveillance for early prostate cancer at a non-academic institutionRiccardo Leni, Marco Roscigno, Paolo Barzaghi, et al.
Pageof 4